Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phosphatidylcholine Supplementation in Infants With Diminished Sensory Gating

NCT01905605 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01905605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01905605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phosphatidylcholine Supplementation in Infants With Diminished Sensory Gating
Lead sponsor
University of Colorado, Denver
Phase
Phase 1/2
Overall status
Withdrawn
Start date
September 30, 2013
Completion date
January 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diminished p50 sensory gating, schizophrenia